Skip to main content

Table 1 The proportion of the HepG2 phase of G0/G1 cells and S in the total number of cells incubated with TGO, TGD and ox-TG

From: Comparison of different polar compounds-induced cytotoxicity in human hepatocellular carcinoma HepG2 cells

 

Time (h)

24

48

Concentration (mg/mL)

G0/G1 (%)

S (%)

G0/G1 (%)

S (%)

Control

0.00

46.32 ± 1.69

41.05 ± 1.33

45.68 ± 0.61

41.67 ± 0.74

TGO

0.05

47.48 ± 1.41

38.93 ± 1.52

46.28 ± 0.15

43.47 ± 0.17

TGO

0.50

45.88 ± 0.64

44.74 ± 0.57

40.25 ± 0.83

49.37 ± 0.97

TGO

2.00

38.84 ± 0.18

49.42 ± 0.17

36.41 ± 0.24

54.54 ± 0.42

TGD

0.05

47.69 ± 1.59

42.95 ± 1.44

43.40 ± 0.56

42.96 ± 0.18

TGD

0.50

43.20 ± 0.10

47.62 ± 0.32

38.63 ± 0.78

50.00 ± 0.57

TGD

2.00

37.60 ± 0.08

50.49 ± 0.09

33.87 ± 0.85

57.68 ± 0.76

ox-TG

0.05

40.36 ± 1.35

49.42 ± 1.46

38.18 ± 0.32

50.49 ± 0.34

ox-TG

0.50

37.06 ± 0.63

49.69 ± 0.61

36.41 ± 0.79

51.55 ± 0.68

ox-TG

2.00

33.67 ± 0.27

54.92 ± 0.18

29.74 ± 0.35

57.60 ± 0.45